Nutraceutical Panel References

References:

1. Regenesis [Monograph]. (2008). "Sulforaphane: A multifunctional molecular weapon targeting disease processes at their most fundamental molecular origins."
2. Brooks, J., V. Paton, et al. (2001). "Potent Induction of Phase 2 Enzymes in Human Prostate Cells by Sulforaphane 1." Cancer Epidemiology Biomarkers & Prevention 10(9): 949-954.
3. Young G, Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev. 2005 Jan;45(1):1-28.
4. Hulbert, A. (2007). "Membrane fatty acids as pacemakers of animal metabolism." Lipids 42(9): 811-819.
   
5. Bannenberg, G., M. Arita, et al. (2007). "Endogenous Receptor Agonists: Resolving Inflammation." TheScientificWorldJOURNAL 7: 1440-1462.
6. Singh, M. (2005). "Essential fatty acids, DHA and human brain." Indian Journal of Pediatrics 72(3): 239-242.
7. Serhan, C. N. (2005). "Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution." Prostaglandins, Leukotrienes & Essential Fatty Acids 73(3-4): 141-162.
8. Serhan, C. N., M. Arita, et al. (2004). "Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers." Lipids 39(11): 1125-1132.
9. Bannenberg, G., M. Arita, et al. (2007). "Endogenous Receptor Agonists: Resolving Inflammation." TheScientificWorldJOURNAL 7: 1440-1462.
10. Stix, G. (2007). "A Malignant Flame." Scientific American Magazine 297(1): 60-67.
11. Taranova, A. G., D. Maldonado, III, et al. (2008). "Allergic Pulmonary Inflammation Promotes the Recruitment of Circulating Tumor Cells to the Lung." Cancer Res 68(20): 8582-8589.
12. JM., W., Nutritional and botanical modulation of the inflammatory cascadeeicosanoids, cyclooxygenases and lipoxygenases as an adjunct in cancer
    therapy. . Integr. Cancer Ther., 2002. 1: p. 7-37.
13. Kobayashi T, Hashimoto S, et al. Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol. 1997 Oct 1;54(7):819-24.
14. Ritter L; Solomon KR, Forget J, Stemeroff M, O'Leary C.. "Persistent organic pollutants". United Nations Environment Programme. http://www.chem.unep.ch/pops/ritter/en/ritteren.pdf. [Register to download this pdf]
15. Beliveau R, G. D. (2006). Foods that Fight Cancer Allen & Unwin.
16. Folkman, J. and R. Kalluri (2004). "Cancer without disease." Nature 427(6977): 787-787.
17. Phillip Stricker., K. P. (2008). Prostate Cancer For the General Practitioner The Prostate Cancer Foundation of Australia.
18. Ho, S., W. Tang, et al. (2006). "Developmental Exposure to Estradiol and Bisphenol A Increases Susceptibility to Prostate Carcinogenesis and Epigenetically Regulates Phosphodiesterase Type 4 Variant 4." Cancer Research 66(11): 5624.
19. Science Daily [http://www.sciencedaily.com/releases/2006/06/060601092831.htm]
20. Chen, K., F. Li, et al. (2006). "Induction of leptin resistance through direct interaction of C-reactive protein with leptin." Nature Medicine 12: 425-432.
21. Kang., S., Decrement of adipocyte size and preventionof hyperlepinemia by garlic in high fat diet- induced obese rats Asia Pacific Journal of Clincal Nutrition 2005(14): p. (Suppl).
22. Yeh, Y.Y. and L. Liu, Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies. J Nutr, 2001. 131(3s): p. 989S-93S.
23. Nishimura, H., O. Higuchi, and K. Tateshita, Antioxidative activity of sulfur-containing compounds in Allium species for human LDL oxidation in vitro. Biofactors, 2004. 21(1-4): p. 277-80.
24. Clarke, J., R. Dashwood, et al. (2008). "Multi-targeted prevention of cancer by sulforaphane." Cancer Letters 269(2): 291-304.
25. Munday, R., P. Mhawech-Fauceglia, et al. (2008). "Inhibition of Urinary Bladder Carcinogenesis by Broccoli Sprouts." Cancer Res 68(5): 1593-1600.
26. Degner, S. and D. Romagnolo (2009). "Phytochemicals and Anticancer Mechanisms." Botanical Medicine in Clinical Practice: 388.
27. Schattner, E., R. Furman, et al. (2006). "NF-KB in Human Cancers." NF-kB/Rel Transcription Factor Family: 131.
28. The Linus Pauling Institute. Oregan State University. Web based micronutrient research. lpi.oregonstate.edu/infocenter.
29. Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23(2):151-152.
30. Mukherjee S et al. Broccoli: A Unique Vegetable That protects Mammalian hearts through
    the Redox Cycling of the Thioredoxin Superfamily J. Agric.Food.Chem. 2008;56:609-617
31. Thejass, P. and G. Kuttan (2007). "Immunomodulatory activity of Sulforaphane, a naturally occurring isothiocyanate from broccoli (Brassica oleracea)." Phytomedicine 14(7-8): 538-545.
32. Fattore, E., R. Fanelli, et al. (2002). "Persistent organic pollutants in food: public health implications." J Epidemiol Community Health 56(11): 831-832.
33. Powers KM, Smith-Weller T, et al. Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology. 2003 Jun 10;60(11):1761-6.
34. Logroscino G, Marder K, et al. Dietary lipids and antioxidants in Parkinson’s disease: a population-based, case-control study. Ann Neurol. 1996 Jan;39(1):89-94.
35. Shults CW, Haas RH, et al. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol. 1997 Aug;42(2):261-4.
36. Shults CW, Oakes D, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002 Oct;59(10):1541-50.
37. Ji Man Han et al. Protective Effect of Sulforaphane against Dopaminergic Cell Death The
    Journal of Pharmacology and Experimental Therapeutics 2007;321(1):249-256
38. Atasoy HT, Nuyan O, et al. T2-weighted MRI in Parkinson’s disease: substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol India. 2004 Sep;52(3):332-7.
39. Ross GW, Petrovitch H, et al. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol. 2004 Oct;56(4):532-9.
40. Mazzio E, Huber J, et al. Effect of antioxidants on L-glutamate and N-methyl-4-phenylpyridinium ion induced-neurotoxicity in PC12 cells. Neurotoxicology. 2001 Apr;22(2):283-8.
41. Castorina M, Ferraris L. Acetyl-L-carnitine affects aged brain receptorial system in rodents. Life Sci. 1994;54(17):1205-14.
42. Bottiglieri, T., S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule. Am. J. Clinical Nutrition, 2002. 76(5): p. 1151S-1157.
43. McFadden SA. Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways. Toxicology. 1996 Jul 17;111(1-3):43-65.
44. Mizuta E, Kuno S. Rotations induced by L-dopa in parkinsonian rats are reduced by an ingestion of amino acids. J Neural Transm Park Dis Dement Sect. 1993;6(3):211-4.
45. O'Ryrne, P. (1997). "Leukotrienes in the pathogenesis of asthma." Chest 111: 27S-34S.
46. Bede O, Suranyi A, et al. Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: A randomized, placebo-controlled, double-blind study. Magnes Res. 2003 Dec;16(4):262–70.
47. Lu YP, Lou YR, Lin Y, et al. Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Res. 2001;61(13):5002-5009.
48. Jung, Y. and L. Ellis (2001). "Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea." International journal of experimental pathology 82(6): 309-316.
49. Kao, Y., R. Hiipakka, et al. (2000). Modulation of obesity by a green tea catechin, Am Soc Nutrition. 72: 1232-1233.
50. Andreasen, P., L. Kjoller, et al. (1997). "The urokinase-type plasminogen activator system in cancer metastasis: a review." International Journal of Cancer 72(1).
51. Hyman, M. (March 2009). "Healing the Broken Brain Syndrome." Life Extension 15:3.
52. Werbach MR (1999) Textbook of Clinical Medicine, Third Line Press, Inc, CA
53. Jamison, J. (2003). Clinical guide to nutrition and dietary supplements in disease management, Churchill Livingstone.
54. Bounous G., Batist G, Gold P. Immunoenhancing property of dietary whey protein in mice: role
    of glutathione. Clin Invest Med 12: 154-61, 1989.
55. Bounous G., Batist G., Gold P. Whey proteins in cancer prevention. Cancer letters 57, 91-94,1991.
56. Corbett TH, Griswold DP, Roberts GJ, Peckham JC et al. Evaluation of single agents and combinations of
    chemotherapeutic agents in mouse colon carcinogenesis. Cancer 40 : 2650, 1977.
    Rodent chow (purina) containing varying amounts of beef, fish, corn, and whey proteins.
57. Bounous, G. (2000). "Whey protein concentrate (WPC) and glutathione modulation in cancer treatment." Anticancer research 20(6): 4785-4792.
58. Argiles JM, Lopez-Soriano. Insulin and cancer. Int J Oncol 2001; 18:683-687.
59. Bruning PF, Bonfret JMG, Van Nooyrd PAH, Hart AA, De Jong-Bakker M, Noojen WJ. Insulin resistance and breast cancer risk. Int J Cancer 1992; 52:511-516.
60. DelGiudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, et al. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Research and Treatment 1998; 111-120.
61. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madamas Y, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2001; 20:42-51.
62. Goodwin PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A, et al. Elevated levels of plasma triglycerides are associated with premenopausal breast cancer risk. Nutr Cancer 1997; 27:284-292.
63. Glicksman AS, Myers WPL, Rawson RW. Diabetes mellitus and carbohydrate metabolism inpatients with cancer. Med Clin N Amer 1956; 40: 887-900.
64. Goodwin PJ, Boyd NF. Body size and breast cancer prognosis. A critical review. Breast Cancer Res Treat 1990; 16: 205-214.
65. Reaven, G. M. Syndrome X Insulin Resistance, Hyperinsulinemia, And Coronary Heart Disease, www.endotext.com.
66. Riboli, E. and T. Norat (2003). "Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk." The American journal of clinical nutrition 78(3): 559-569.
67. Zakkar, M., K. Van der Heiden, et al. (2009). "Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State." Arteriosclerosis, Thrombosis, and Vascular Biology.
68. Middleton, E., Jr, G. Drzewiecki, et al. (1981). "Quercetin: an inhibitor of antigen-induced human basophil histamine release." J Immunol 127(2): 546-550.
69. O'Byrne, P. (1997). "Leukotrienes in the pathogenesis of asthma." Chest 111: 27S-34S.
70. Kimball’s Biology Pages: http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/A/Allergies.html
71. Goetzl, E., D. Payan, et al. (1984). "Immunopathogenetic roles of leukotrienes in human diseases." Journal of clinical immunology 4(2): 79-84.
72. Haberal, I. and J. Corey (2003). "The role of leukotrienes in nasal allergy." Otolaryngology-Head and Neck Surgery 129(3): 274-279.
73. Zhang, S., W. Willett, et al. (2003). "A prospective study of plasma total cysteine and risk of breast cancer." Cancer Epidemiology Biomarkers & Prevention 12(11): 1188.
74. Koopman, R., A. Wagenmakers, et al. (2005). "Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis in vivo in male subjects." American Journal of Physiology- Endocrinology And Metabolism 288(4): E645.
75. Rieu, I., M. Balage, et al. (2006). "Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia." The Journal of physiology 575(1): 305.
76. Scholz-Ahrens, K. E., G. Schaafsma, et al. (2001). "Effects of prebiotics on mineral metabolism." Am J Clin Nutr 73(2): 459S-464.
77. Cordain, L. (2002). The Paleo Diet, New York: John Wiley & Sons.
78. Katsanos, C., H. Kobayashi, et al. (2006). "A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly." American Journal of Physiology- Endocrinology And Metabolism 291(2): E381.